Level Biotechnology Inc. (3118.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$30.60 (-0.65%) as of
Key statistics
- Market cap
- 993.06M
- P/E (TTM)
- 13.13
- EPS (TTM)
- 2.33
- Dividend yield
- 7.14%
- 52-week range
- 30.40 – 34.70
- Beta
- 0.23
- Revenue (TTM)
- 709.37M
- Profit margin
- 10.72%
- Volume
- 5.09k
About Level Biotechnology Inc.
Level Biotechnology Inc. engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan. The company markets and distributes biomedical precision equipment. It also provides services in the areas of mammalian and genetic toxicology, pharmacology, biocompatibility, and model animal production. In addition, it offers preclinical research services to the biotech, pharmaceutical, medical device, animal health, and agrichemical industries. The company was founded in 1989 and is headquartered in New Taipei City, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- New Taipei City, Taiwan
- Employees
- 128
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.